Browsing Pharmacy Research by Author "Bader, Loulia"
Now showing items 1-4 of 4
-
A cross-sectional analysis of zinc and copper levels and their relationship to cardiovascular disease risk markers in Qatar biobank participants
Kerkadi, Abdelhamid; Raïq, Hicham; Prince, Mohammad Shoaib; Bader, Loulia; Soltani, Abderrezzaq; Agouni, Abdelali... more authors ... less authors ( Frontiers Media , 2023 , Article)Cardiovascular diseases (CVD) are the leading cause of mortality and morbidity worldwide. Dietary intake, particularly zinc (Zn) and copper (Cu) has been strongly associated with CVD. These trace elements play a crucial ... -
Genetic and non-genetic factors impact on inr normalization in preprocedural warfarin management
Eljilany, Islam; Elarref, Mohamed; Shallik, Nabil; Elzouki, Abdel Naser; Bader, Loulia; El-Bardissy, Ahmed; Abdelsamad, Osama; Al-Badriyeh, Daoud; Cavallari, Larisa H.; Elewa, Hazem... more authors ... less authors ( Dove Medical Press , 2021 , Article)Background: Annually, 10% of warfarin patients will likely need to stop warfarin prior to elective surgery to achieve a baseline international normalization ratio (INR) level (INR ≤ 1.2) at the time of the procedure. This ... -
Genetic Factors Associated with Morphine Consumption in Women Undergoing Laparoscopic Cholecystectomy: A Prospective Cohort Study.
Elgendy, Hamed M; Ibrahim, Sami M; Bader, Loulia; Mohammad, Rudaina A; Ali, Zainab O; Bejaoui, Mohamed Ben Allala; Hilani, Mohamad; Ismail, Hesham; Elewa, Hazem F... more authors ... less authors ( Dove Press Ltd , 2023 , Article)Morphine has been a crucial analgesic agent used perioperatively in various surgical procedures. Genetic factors can lead to morphine dose requirement interpatient variability. Our objective was to determine the contribution ... -
Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations
El Rouby, Nihal; Shahin, Mohamed H.; Bader, Loulia; Khalifa, Sherief I.; Elewa, Hazem ( Wiley-Blackwell , 2022 , Article)To date, there has been no genomewide association study (GWAS) from the Middle East and North African (MENA) region to identify genetic variants associated with warfarin dose variability using this approach. In this study, ...